SeekingAlpha · Aug 28, 2026
Encompass Health Is Healthy Enough To Justify A Bullish View
Encompass Health is rated a Buy due to its compelling growth prospects, operational excellence, and strong position. Read more on EHC stock here.
EH
NYSE · EHC
Encompass Health Corporation
Healthcare · Medical - Care Facilities
$120.21
Down-$0.64 (-0.53%)
Updated Sep 1, 2026, 4:15 AM
SID Score
6.3/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 10.75B
- P/E ratio
- 19.85
- Dividend yield
- 0.74%
- 52-week range
- $92.77 – $127.99
- Volume
- 720.73K
- Avg. volume
- 837.24K
Price performance
EHC price history
1M range · 0 trading sessions · Daily adjusted prices
EHC does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest EHC news
The latest Smart Investors Daily articles mentioning EHC.
Stock researchCompany · Overview
EHC research
Overview
Company profile and research snapshot.
Company profile
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $146.67
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | TD Cowen | Buy | — |
| Aug 7, 2026 | UBS | Buy | — |
| Aug 7, 2026 | Truist Securities | Buy | — |
| Aug 6, 2026 | Barclays | Overweight | — |
| May 28, 2026 | TD Cowen | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 23, 2026
Encompass Health (EHC) Could Be 19% Undervalued On Its Growth Narrative
Encompass Health (EHC) has put a fresh financing framework in place, filing an omnibus shelf registration that covers potential future offerings of common and preferred stock, warrants and debt securities. See our latest analysis for Encompass Health. Encompass Health shares have eased in the past week following the shelf registration and recent $100 million senior notes issuance, although a 30 day share price return of 6.57% and a 3 year total shareholder return of 77.79% indicate momentum...
Yahoo · Aug 23, 2026
Encompass Health (EHC) Stock Gets Fair Value Bump After Analysts Lift Targets
Encompass Health is back in focus as analysts edge their price targets higher, with fair value estimates moving from about US$145.25 to roughly US$148.17. Much of this shift traces to recent Q2 results, updated 2026 guidance, and a wave of research that now clusters price targets in the US$144 to US$150 range. As you read on, you will see what is driving these revisions and how to track the next moves in the Encompass Health story. Stay updated as the Fair Value for Encompass Health shifts by...
Yahoo · Aug 23, 2026
Encompass Health (EHC) Stock May Be 16% Undervalued As Cash Flow Holds Up
Encompass Health stock has more than doubled over the past 5 years, yet current checks still suggest the shares trade at a discount to an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and to what earnings multiples imply. Encompass Health has returned about 105.2% over 5 years, which puts current investors in the position of weighing further upside against the gains already on the table. Expectations for continued cash flow generation from its rehabilitation...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
